Blueberry Enhances Activity and Cognition Through Increased Vascular Efficiency
BEACTIVE
Effects of Blueberry Consumption on Vascular Function, Physical Activity, and Cognition in Sedentary Older Adults
1 other identifier
interventional
84
1 country
1
Brief Summary
Recent evidence suggests that increased berry intake results in a variety of health benefits, across multiple health domains. This 3-month randomized, double-blind, placebo-controlled trial assess the effects of combining daily blueberry intake with weekly exercise (BB-EX) on cardiovascular function, as well as physical activity and cognitive function, in sedentary older adults (\>60 years). We will compare these effects to the same outcomes with a control group consuming a blueberry placebo (P-EX) at 0, 4, 8 and 12 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2019
CompletedFirst Posted
Study publicly available on registry
August 8, 2019
CompletedStudy Start
First participant enrolled
September 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 22, 2022
CompletedJanuary 20, 2023
January 1, 2023
3.2 years
July 23, 2019
January 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in pulse wave velocity at 12 weeks
Change in carotid-femoral pulse wave velocity will be assessed using applanation tonometry, (SphygmoCor Pulse Wave Velocity System)
0 to 12 weeks
Secondary Outcomes (8)
Change from baseline in cognitive flexibility at 12 weeks
0 to 12 weeks
Change from baseline in physical activity at 12 weeks
0 to 12 weeks
Change from baseline in ambulatory blood Pressure at 12 weeks
0 to 12 weeks
Change from baseline in total calories at 4, 8 and 12 weeks
0 to 12 weeks (0, 4, 8 and 12 weeks)
Change from baseline in macronutrient intake at 4, 8 and 12 weeks
0 to 12 weeks (0, 4, 8 and 12 weeks)
- +3 more secondary outcomes
Other Outcomes (17)
Change from baseline in central arterial pressure at 12 weeks
0 to 12 weeks
Baseline dietary intake (Total calories)
0 weeks
Baseline dietary intake (macronutrient intake)
0 weeks
- +14 more other outcomes
Study Arms (2)
Blueberry Plus Exercise (BB-EX)
EXPERIMENTALBB-Ex participants will consume lyophilized blueberry powder, mixed with water (18 grams, equivalent to 3/4ths cup of blueberries) with 2 daily meals (36 g/d blueberry powder total; approx. 1.5 servings/d)
Blueberry Placebo Plus Exercise (P-EX)
PLACEBO COMPARATORParticipants randomized to P-EX treatment will consume an indistinguishable placebo powder, matched for color, flavor, consistency, and caloric content, in the same manner.
Interventions
Pre-packaged blueberry powders are from U.S. Highbush Blueberry Council and are packaged in sealed single-serving packets (18 g/packet) to prevent exposure to light and moisture. All supplement packets are stored under refrigeration until distribution to study participants. Participants will be asked to increase physical activity through a weekly supervised exercise class and increasing baseline daily step counts gradually over the course of the intervention.
Pre-packaged placebo powders are from U.S. Highbush Blueberry Council and are packaged in sealed single-serving packets (18 g/packet) to prevent exposure to light and moisture. All supplement packets are stored under refrigeration until distribution to study participants. Participants will be asked to increase physical activity through a weekly supervised exercise class and increasing baseline daily step counts gradually over the course of the intervention.
Eligibility Criteria
You may qualify if:
- Age 60 and older
- Overweight (BMI ≥25 to 35 kg/m2)
- Well-controlled blood pressure (\< 150/90 mmHg)
- Able to speak and understand spoken and written English
- Cognitively normal (Mini-Cog score 3-5)
- Able to walk independently
- Social security number (required for compensation)
- Own a smartphone or other mobile device capable of downloading the Garmin Connect app
You may not qualify if:
- Exercise \> 150 minutes/week
- Unwillingness or inability to be randomized to any one of two intervention groups without knowing which (double-blind), submit to all study testing, or continuously participate in a randomly assigned diet and exercise intervention for six months.
- Unwilling to restrict consumption of anthocyanin-rich foods
- Unwillingness to abstain from mood altering drugs (including marijuana but excluding CBDs) for 7 days prior to baseline and endpoint testing.
- Self-reported vegetarian or vegan.
- Inability to complete written recording forms including journals of eating and exercise behaviors.
- Inability to complete written and computerized cognitive tasks (presented in English).
- Allergy or intolerance to blueberry or placebo powder ingredients Placebo ingredients include: maltodextrin, fructose, artificial blueberry flavor, natural blueberry flavor, artificial purple color (water, FD\&C Red #40, FD\&C Blue #1, malic acid, sodium benzoate) citric acid, and artificial red color (water, FD\&C Red #40, malic acid, sodium benzoate, silica dioxide).
- Gastrointestinal disorders that influence digestion and absorption of food, e.g., IBD
- History of frequent urinary tract or Clostridium difficile infections
- Presence of unstable, acutely symptomatic, or life-limiting illness.
- Regular use of medication that interferes with the measurement of study outcomes as determined by the study physician.
- Unstable use of medications, other than statins, for conditions associated with metabolic syndrome (hypertension, diabetes, dyslipidemia) during the prior 6 months or during the study.
- Antibiotic use in the last 3 months.
- Cigarette smoking, chewing, or use of nicotine replacement products in the past 3 months or during the course of the study.
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- U.S. Highbush Blueberry Councilcollaborator
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
Related Publications (5)
Miller MG, Hamilton DA, Joseph JA, Shukitt-Hale B. Dietary blueberry improves cognition among older adults in a randomized, double-blind, placebo-controlled trial. Eur J Nutr. 2018 Apr;57(3):1169-1180. doi: 10.1007/s00394-017-1400-8. Epub 2017 Mar 10.
PMID: 28283823BACKGROUNDMichalska A, Lysiak G. Bioactive Compounds of Blueberries: Post-Harvest Factors Influencing the Nutritional Value of Products. Int J Mol Sci. 2015 Aug 10;16(8):18642-63. doi: 10.3390/ijms160818642.
PMID: 26266408BACKGROUNDWhyte AR, Cheng N, Fromentin E, Williams CM. A Randomized, Double-Blinded, Placebo-Controlled Study to Compare the Safety and Efficacy of Low Dose Enhanced Wild Blueberry Powder and Wild Blueberry Extract (ThinkBlue) in Maintenance of Episodic and Working Memory in Older Adults. Nutrients. 2018 May 23;10(6):660. doi: 10.3390/nu10060660.
PMID: 29882843BACKGROUNDJohnson SA, Figueroa A, Navaei N, Wong A, Kalfon R, Ormsbee LT, Feresin RG, Elam ML, Hooshmand S, Payton ME, Arjmandi BH. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial. J Acad Nutr Diet. 2015 Mar;115(3):369-377. doi: 10.1016/j.jand.2014.11.001. Epub 2015 Jan 8.
PMID: 25578927BACKGROUNDReis JF, Monteiro VV, de Souza Gomes R, do Carmo MM, da Costa GV, Ribera PC, Monteiro MC. Action mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studies. J Transl Med. 2016 Nov 15;14(1):315. doi: 10.1186/s12967-016-1076-5.
PMID: 27846846BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William Kraus, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2019
First Posted
August 8, 2019
Study Start
September 20, 2019
Primary Completion
November 22, 2022
Study Completion
November 22, 2022
Last Updated
January 20, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share